Vetoquinol (FRA:8JM) Short-term investments

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:8JM Vetoquinol SA FRA:8JM
87 GF Score
Price €69.70
GF Value €84.66
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Vetoquinol Short-term investments?

Short-term investments only applies to insurance companies.

FRA:8JM
87GF Score
Vetoquinol SA FRA:8JM
Short-term investments is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Vetoquinol (FRA:8JM) Overvalued in 2026?

Based on GuruFocus' analysis, Vetoquinol stock appears to be undervalued. The current stock price of €69.70 is trading 17.7% below its estimated GF Value™ of €84.66. GuruFocus considers Vetoquinol to be Modestly Undervalued.

Key valuation signals for FRA:8JM:

  • Short-term investments:
  • GF Value™: €84.66 vs. price of €69.70 (17.7% below fair value)
  • GF Score™: 87/100 with 1 warning sign

No single metric tells the full story. See the FRA:8JM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Vetoquinol Business Description

Other Exchanges 0O1O:UKVETO:France
Address Magny-Vernois, BP 189, Lure cedex, FRA, 70204
Vetoquinol SA operates is a France-based firm serving in the healthcare market. Its focus lies on developing and marketing veterinary drugs mainly in the European region and to a certain extent in America and Asia. Its portfolio of drugs entails anti-infectives, anti- pain inflammatory drugs, cardiovascular and nephrology treatment intended mainly for pets and livestock.
87GF Score

Get the complete analysis for FRA:8JM

Short-term investments is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€69.70
Price
€84.66
GF Value